229 related articles for article (PubMed ID: 19937925)
1. Mechanism of NSF: New evidence challenging the prevailing theory.
Newton BB; Jimenez SA
J Magn Reson Imaging; 2009 Dec; 30(6):1277-83. PubMed ID: 19937925
[TBL] [Abstract][Full Text] [Related]
2. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
Sieber MA; Pietsch H; Walter J; Haider W; Frenzel T; Weinmann HJ
Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
Peak AS; Sheller A
Ann Pharmacother; 2007 Sep; 41(9):1481-5. PubMed ID: 17684032
[TBL] [Abstract][Full Text] [Related]
4. [Nephrogenic systemic fibrosis and gadolinium-based contrast media].
Andréjak M; Thuillier D; Lok C; Gras-Champel V
Therapie; 2007; 62(2):169-72. PubMed ID: 17582319
[TBL] [Abstract][Full Text] [Related]
5. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
Lim YL; Lee HY; Low SC; Chan LP; Goh NS; Pang SM
Clin Exp Dermatol; 2007 Jul; 32(4):353-8. PubMed ID: 17433041
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
Kalb RE; Helm TN; Sperry H; Thakral C; Abraham JL; Kanal E
Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707
[TBL] [Abstract][Full Text] [Related]
7. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
Abraham JL; Thakral C; Skov L; Rossen K; Marckmann P
Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
[TBL] [Abstract][Full Text] [Related]
8. Tissue deposition of gadolinium and development of NSF: a convergence of factors.
Perazella MA
Semin Dial; 2008; 21(2):150-4. PubMed ID: 18226004
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium and nephrogenic systemic fibrosis: association or causation.
Kurtkoti J; Snow T; Hiremagalur B
Nephrology (Carlton); 2008 Jun; 13(3):235-41. PubMed ID: 18221255
[TBL] [Abstract][Full Text] [Related]
10. [Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents--a status paper].
Heinrich M; Uder M
Rofo; 2007 Jun; 179(6):613-7. PubMed ID: 17497597
[TBL] [Abstract][Full Text] [Related]
11. Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis.
Edward M; Quinn JA; Mukherjee S; Jensen MB; Jardine AG; Mark PB; Burden AD
J Pathol; 2008 Apr; 214(5):584-93. PubMed ID: 18220317
[TBL] [Abstract][Full Text] [Related]
12. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure.
Grobner T; Prischl FC
Semin Dial; 2008; 21(2):135-9. PubMed ID: 18226001
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure.
Deo A; Fogel M; Cowper SE
Clin J Am Soc Nephrol; 2007 Mar; 2(2):264-7. PubMed ID: 17699423
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium deposition in nephrogenic fibrosing dermopathy.
Boyd AS; Zic JA; Abraham JL
J Am Acad Dermatol; 2007 Jan; 56(1):27-30. PubMed ID: 17109993
[TBL] [Abstract][Full Text] [Related]
15. [Nephrogenic systemic fibrosis as an adverse drug reaction of gadolinium-based contrast media for magnetic resonance imaging].
Giersig C
Radiologe; 2007 Sep; 47(9):794-9. PubMed ID: 17713753
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium and nephrogenic systemic fibrosis.
Grobner T; Prischl FC
Kidney Int; 2007 Aug; 72(3):260-4. PubMed ID: 17507905
[TBL] [Abstract][Full Text] [Related]
17. Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?
Bongartz G
MAGMA; 2007 Apr; 20(2):57-62. PubMed ID: 17436028
[TBL] [Abstract][Full Text] [Related]
18. Nephrogenic systemic fibrosis.
Martin DR
Pediatr Radiol; 2008 Jan; 38 Suppl 1():S125-9. PubMed ID: 18071694
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil elastase in the development of nephrogenic systemic fibrosis (NSF)-like skin lesion in renal failure mouse model.
Kartamihardja AAP; Amalia SN; Sekiguchi A; Bhattarai A; Taketomi-Takahashi A; Motegi SI; Koyama H; Tsushima Y
PLoS One; 2021; 16(10):e0259211. PubMed ID: 34705860
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium.
Cowper SE
Adv Dermatol; 2007; 23():131-54. PubMed ID: 18159899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
